SCHEMBL5489532

SCHEMBL5489532

CSc1nc2c(Cl)cc(S(N)(=O)=O)cc2o1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 12/20 0.41
CA1 P00915 11/20 0.41
CA9 Q16790 9/20 0.41
CA12 O43570 3/20 0.38
CA7 P43166 3/20 0.38
TDP1 Q9NUW8 2/20 0.38
CA4 P22748 2/20 0.38
CA6 P23280 2/20 0.38
CA5A P35218 2/20 0.38
CA14 Q9ULX7 2/20 0.38
CA5B Q9Y2D0 2/20 0.38
LMNA P02545 1/20 0.38
CYP2C9 P11712 1/20 0.38
CA13 Q8N1Q1 1/20 0.38
POLB P06746 1/20 0.38
APEX1 P27695 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
PKM P14618 1/20 0.33
MAOA P21397 1/20 0.33
MAOB P27338 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3574530 0.72 CA1 (0.42) CA2CA1CA9CA12CA7
SCHEMBL3573726 0.71 HTT (0.50) CA2CA1CA9CA12TDP1
SCHEMBL10813010 0.67 TDP1 (0.54) TDP1LMNAPOLB
SCHEMBL21130523 0.66 TDP1 (0.41) TDP1PKM
SCHEMBL14508206 0.65 ELANE (0.39) TDP1LMNAPOLBL3MBTL1PKM
SCHEMBL14508173 0.63 ELANE (0.40) TDP1LMNAPKMPTGS2
SCHEMBL7993257 0.62 CA2 (0.75) CA2CA1CA9CA12CA7
SCHEMBL5489529 0.62 ALDH1A1 (0.36) LMNAPOLB
SCHEMBL26361756 0.61 TDP1 (0.42) TDP1PKM
SCHEMBL3781532 0.60 CA1 (1.00) CA2CA1CA9CA12CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1858901-A1 BENZOTHIAZOLE, THIAZOLOPYRIDINE, BENZOOXAZOLE AND OXAZOLOPYRIDINE DERIVATIVES AS ANTIDIABETIC COMPOUNDS F. Hoffmann-La Roche AG (CH) 2007-11-28 EP disclosed
WO-2006094682-A1 BENZOTHIAZOLE, THIAZOLOPYRIDINE, BENZOOXAZOLE AND OXAZOLOPYRIDINE DERIVATIVES AS ANTIDIABETIC COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2006-09-14 WO disclosed